Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 33, 2019 - Issue 12
221
Views
3
CrossRef citations to date
0
Altmetric
Short Communication

Saponin-rich fraction from Agave sisalana: effect against malignant astrocytic cells and its chemical characterisation by ESI-MS/MS

, ORCID Icon, , , , , , , , , & show all
Pages 1769-1772 | Received 29 Oct 2017, Accepted 25 Jan 2018, Published online: 02 Feb 2018

References

  • Chen PY, Chen CH, Kuo CC, Lee TH, Kuo YH, Lee CK. 2011. Cytotoxic steroidal saponins from Agave sisalana. Planta Med. 77:929–933.10.1055/s-0030-1250672
  • Li Y, Liu C, Xiao D, Han J, Yue Z, Sun Y, Fan L, Zhang F, Meng J, Zhang R, et al. 2015. Trillium tschonoskii steroidal saponins suppress the growth of colorectal Cancer cells in vitro and in vivo. J Ethnopharmacol. 168:136–145.10.1016/j.jep.2015.03.063
  • Nagel ZD, Kitange GJ, Gupta SK, Joughin BA, Chaim IA, Mazzucato P, Lauffenburger DA, Sarkaria JN, Samson LD. 2017. DNA repair capacity in multiple pathways predicts chemoresistance in glioblastoma multiforme. Cancer Res. 77:198–206.10.1158/0008-5472.CAN-16-1151
  • Santos JDG, Vieira IJC, Filho RB, Branco A. 2015. Chemicals from Agave sisalana biomass: isolation and identification. Int J Mol Sci. 16:8761–8771.10.3390/ijms16048761
  • Silva VDA, Pitanga BP, Nascimento RP, Souza CS, Coelho PL, Menezes-Filho N, Silva AMM, Costa MFD, El-Bachá RS, Velozo ES, Costa SL. 2013. Juliprosopine and juliprosine from Prosopis juliflora leaves induce mitochondrial damage and cytoplasmic vacuolation on co-cultured glial cells and neurons. Chem Res Toxicol. 26:1810–1820.10.1021/tx4001573
  • Thon N, Thorsteinsdottir J, Eigenbrod S, Schüller U, Lutz J, Kreth S, Belka C, Tonn JC, Niyazi M, Kreth FW. 2016. Outcome in unresectable glioblastoma: MGMT promoter methylation makes the difference. J Neurol. 264:350–358.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.